
Complication Rates of BMAC vs Other Injectables for Knee Osteoarthritis

Complication Rates of BMAC vs Other Injectables for Knee Osteoarthritis
Complication rates of bone marrow aspirate concentrate injections versus other injectable therapies for knee osteoarthritis: A systematic review and meta-analysis.
J Orthop. 2025 01-Apr;():. 10.1016/j.jor.2024.10.005Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Six randomized controlled trials including 860 patients with knee osteoarthritis were included in this systematic review and meta-analysis comparing bone marrow aspirate concentrate (BMAC) injections versus other injectable therapies. Pooled outcomes of interest included overall complication rates, early (≤7 days) complications, late (>7 days) complications, type of complication (pain, effusion, i...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Learn about our AI Driven
High Impact Search Feature

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.